[go: up one dir, main page]

NO20000731L - Neisseria lactoferinbindingsprotein - Google Patents

Neisseria lactoferinbindingsprotein

Info

Publication number
NO20000731L
NO20000731L NO20000731A NO20000731A NO20000731L NO 20000731 L NO20000731 L NO 20000731L NO 20000731 A NO20000731 A NO 20000731A NO 20000731 A NO20000731 A NO 20000731A NO 20000731 L NO20000731 L NO 20000731L
Authority
NO
Norway
Prior art keywords
lactoferin
neisseria
binding protein
polypeptides
polynucleotides
Prior art date
Application number
NO20000731A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000731D0 (no
Inventor
Annika Mar Pettersson-Fernholm
Johannes Petrus Mari Tommassen
Original Assignee
Univ Utrecht
Stw Technology Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9717423.9A external-priority patent/GB9717423D0/en
Priority claimed from GBGB9802544.8A external-priority patent/GB9802544D0/en
Application filed by Univ Utrecht, Stw Technology Foundation filed Critical Univ Utrecht
Publication of NO20000731D0 publication Critical patent/NO20000731D0/no
Publication of NO20000731L publication Critical patent/NO20000731L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20000731A 1997-08-15 2000-02-14 Neisseria lactoferinbindingsprotein NO20000731L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9717423.9A GB9717423D0 (en) 1997-08-15 1997-08-15 Vaccine
GBGB9802544.8A GB9802544D0 (en) 1998-02-05 1998-02-05 Vaccine
PCT/EP1998/005117 WO1999009176A1 (fr) 1997-08-15 1998-08-10 Proteine de liaison de lactoferrine de neisseria

Publications (2)

Publication Number Publication Date
NO20000731D0 NO20000731D0 (no) 2000-02-14
NO20000731L true NO20000731L (no) 2000-03-31

Family

ID=26312080

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000731A NO20000731L (no) 1997-08-15 2000-02-14 Neisseria lactoferinbindingsprotein

Country Status (18)

Country Link
US (1) US7105316B2 (fr)
EP (1) EP1003874B1 (fr)
JP (1) JP2001514894A (fr)
KR (1) KR100509712B1 (fr)
CN (1) CN1204253C (fr)
AT (1) ATE344325T1 (fr)
AU (1) AU744733B2 (fr)
BR (1) BR9811907A (fr)
CA (1) CA2301332A1 (fr)
CO (1) CO4810233A1 (fr)
DE (1) DE69836333T2 (fr)
ES (1) ES2275314T3 (fr)
IL (1) IL134436A0 (fr)
NO (1) NO20000731L (fr)
NZ (1) NZ502750A (fr)
PL (1) PL194800B1 (fr)
TR (1) TR200000416T2 (fr)
WO (1) WO1999009176A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258851A1 (fr) * 1999-05-19 2010-12-08 Novartis Vaccines and Diagnostics S.r.l. Compositions à base de combinaisons de Neisseria
GB0007433D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Recombinant transferrin binding proteins
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
GB0107219D0 (en) * 2001-03-22 2001-05-16 Microbiological Res Authority Immunogenic commensal neisseria sequences
AU2003260357B2 (en) 2002-08-02 2009-10-29 Glaxosmithkline Biologicals S.A. Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from lgtB- Neisseria minigitidis
CA2539715C (fr) 2003-10-02 2015-02-24 Glaxosmithkline Biologicals S.A. Antigenes pertussis et leur utilisation dans la vaccination
GB0409748D0 (en) * 2004-04-30 2004-06-09 Chiron Srl Lactoferrin cleavage
CA2654706A1 (fr) 2006-06-12 2007-12-21 Nathalie Devos Vaccin a base de lipooligosaccharide neisseria meningitidis
US20130004530A1 (en) 2010-03-10 2013-01-03 Jan Poolman Vaccine composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6048539A (en) * 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein

Also Published As

Publication number Publication date
IL134436A0 (en) 2001-04-30
WO1999009176A1 (fr) 1999-02-25
ES2275314T3 (es) 2007-06-01
US20040131634A1 (en) 2004-07-08
DE69836333T2 (de) 2007-04-19
PL194800B1 (pl) 2007-07-31
BR9811907A (pt) 2000-08-15
JP2001514894A (ja) 2001-09-18
EP1003874B1 (fr) 2006-11-02
AU744733B2 (en) 2002-02-28
CA2301332A1 (fr) 1999-02-25
NZ502750A (en) 2002-03-01
KR20010022952A (ko) 2001-03-26
CO4810233A1 (es) 1999-06-30
AU9261398A (en) 1999-03-08
EP1003874A1 (fr) 2000-05-31
KR100509712B1 (ko) 2005-08-24
TR200000416T2 (tr) 2000-07-21
CN1275164A (zh) 2000-11-29
US7105316B2 (en) 2006-09-12
ATE344325T1 (de) 2006-11-15
CN1204253C (zh) 2005-06-01
NO20000731D0 (no) 2000-02-14
PL338649A1 (en) 2000-11-06
DE69836333D1 (de) 2006-12-14

Similar Documents

Publication Publication Date Title
IL161016A (en) Polypeptides capable of ang-2 binding
DE60142614D1 (de) Inität
WO1998031799A3 (fr) Polynucleotides et polypeptides codant des recepteurs
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
DE69935220D1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
NO20000731L (no) Neisseria lactoferinbindingsprotein
WO2000015659A3 (fr) Polypeptide stomacal zsig28
EP1243923A4 (fr) Methode de selection d'un remede contre le cancer utilisant des domaines d'interaction de p53 et de la mortaline
WO2002092765A3 (fr) Nouveaux inhibiteurs de la telomerase et utilisations correspondantes
WO1999035266A3 (fr) Urotensine humaine ii
EP0885959A3 (fr) Protéine Wnt-5b humaine
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
DK1122307T3 (da) Human carnosinase 2
NO20016340L (no) Hodetraumeindusert cytoplasmatisk kalsiumbindende protein
WO1999038885A3 (fr) Nouveaux composes
EP0897009A3 (fr) HKABY60 polypeptides
EP0969091A3 (fr) Protein associée à un gène récepteur de la leptine humaine
WO2000042165A3 (fr) Proteine specifique de la moelle osseuse
DK1266008T3 (da) Akut neuroninduceret calciumbindende protein type 1-ligand
AU5990100A (en) ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
WO2001027277A3 (fr) Proteines et polynucleotides codes par ces proteines
DE60136643D1 (de) Neuromedin u delta polypeptide
DK1309690T3 (da) MFQ-111, et humant GTPase-lignende protein
WO2001085937A3 (fr) Nouveau regulateur de signalisation proteine g
WO2001077148A3 (fr) Proteine 1 a liaison peptidique

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application